Clinical outcomes in early-stage NSCLC treated with stereotactic body radiotherapy versus surgical resection

Anticancer Research

Volumn 35, Issue 10, 2015, Pages 5607-5614

  Kastelijn, Elisabeth A ^a   El Sharouni, Sherif Y ^b   Hofman, Frederik N ^a   Van Putte, Bart P ^a   Monninkhof, Evelyn M ^b   Van Vulpen, Marco ^b   Schramel, Franz M N H ^a  

^a ST ANTONIUS HOSPITAL   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Clinical outcome; Non small cell lung cancer; Stage I II; Stereotactic body radiotherapy; Surgery

Indexed keywords

AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; FEMALE; HUMAN; INTERMETHOD COMPARISON; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROPENSITY SCORE; RECURRENCE RISK; RETROSPECTIVE STUDY; STEREOTACTIC BODY RADIATION THERAPY; THORACOTOMY; TREATMENT OUTCOME; VIDEO ASSISTED THORACOSCOPIC SURGERY; ADENOCARCINOMA; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; COMPARATIVE STUDY; FOLLOW UP; LUNG NEOPLASMS; MORTALITY; PATHOLOGY; PROGNOSIS; RADIOSURGERY; SURVIVAL RATE; TUMOR RECURRENCE;

ADENOCARCINOMA; AGED; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PNEUMONECTOMY; PROGNOSIS; RADIOSURGERY; RETROSPECTIVE STUDIES; SURVIVAL RATE; THORACOTOMY;

EID: 84942781221     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Morgensztern D, Ng SH, Gao F and Govindan R: Trends in stage distribution for patients with non-small cell lung cancer: a National Cancer Database survey. J Thorac Oncol 5: 29-33, 2010.
2. De Ruysscher D, Nakagawa K and Asamura H: Surgical and nonsurgical approaches to small-size non-small cell lung cancer. Eur Respir J 44: 483-494, 2014.
3. Howington JA, Blum MG, Chang AC, Balekian AA and Murthy SC: Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 143: e278S-313S, 2013.
4. Shibamoto Y, Hashizume C, Baba F, Ayakawa S, Manabe Y, Nagai A, Miyakawa A, Murai T, Iwata H, Mori Y, Mimura M and Ishikura S: Stereotactic body radiotherapy using a radiobiology-based regimen for stage I non-small cell lung cancer: a multicenter study. Cancer 118: 2078-2084, 2012.
5. Bishawi M, Kim B, Moore WH and Bilfinger TV: Pulmonary function testing after stereotactic body radiotherapy to the lung. Int J Radiat Oncol Biol Phys 82: e107-10, 2012.
6. Solda F, Lodge M, Ashley S, Whitington A, Goldstraw P and Brada M: Stereotactic radiotherapy (SABR) for the treatment of primary non-small cell lung cancer; systematic review and comparison with a surgical cohort. Radiother Oncol 109: 1-7, 2013.
7. Palma D, Lagerwaard F, Rodrigues G, Haasbeek C and Senan S: Curative treatment of stage I non-small cell lung cancer in patients with severe COPD: stereotactic radiotherapy outcomes and systematic review. Int J Radiat Oncol Biol Phys 82: 1149-1156, 2012.
8. Palma D, Visser O, Lagerwaard FJ, Belderbos J, Slotman B and Senan S: Treatment of stage I NSCLC in elderly patients: a population-based matched-pair comparison of stereotactic radiotherapy versus surgery. Radiother Oncol 101: 240-244, 2011.
9. Zheng X, Schipper M, Kidwell K, Lin J, Reddy R, Ren Y, Chang A, Lv F, Orringer M and Spring Kong FM: Survival outcome after stereotactic body radiation therapy and surgery for stage I non-small cell lung cancer: a meta-analysis. Int J Radiat Oncol Biol Phys 90: 603-611, 2014.
10. Crabtree TD, Puri V, Robinson C, Bradley J, Broderick S, Patterson GA, Liu J, Musick JF, Bell JM, Yang M and Meyers BF: Analysis of first recurrence and survival in patients with stage I non-small cell lung cancer treated with surgical resection or stereotactic radiation therapy. J Thorac Cardiovasc Surg 147: 1183-1191; discussion 1191-1192, 2014.
11. Mokhles S, Verstegen N, Maat AP, Birim O, Bogers AJ, Mokhles MM, Lagerwaard FJ, Senan S and Takkenberg JJ: Comparison of clinical outcome of stage I non-small cell lung cancer treated surgically or with stereotactic radiotherapy: Results from propensity score analysis. Lung Cancer 2015.
12. Robinson CG, DeWees TA, El Naqa IM, Creach KM, Olsen JR, Crabtree TD, Meyers BF, Puri V, Bell JM, Parikh PJ and Bradley JD: Patterns of failure after stereotactic body radiation therapy or lobar resection for clinical stage I non-small cell lung cancer. J Thorac Oncol 8: 192-201, 2013.
13. Varlotto J, Fakiris A, Flickinger J, Medford-Davis L, Liss A, Shelkey J, Belani C, DeLuca J, Recht A, Maheshwari N, Barriger R, Yao N and DeCamp M: Matched-pair and propensity score comparisons of outcomes of patients with clinical stage I non-small cell lung cancer treated with resection or stereotactic radiosurgery. Cancer 119: 2683-2691, 2013.
14. Verstegen NE, Oosterhuis JW, Palma DA, Rodrigues G, Lagerwaard FJ, van der Elst A, Mollema R, van Tets WF, Warner A, Joosten JJ, Amir MI, Haasbeek CJ, Smit EF, Slotman BJ and Senan S: Stage I-II non-small cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-assisted thoracoscopic surgery (VATS): outcomes of a propensity score-matched analysis. Ann Oncol 24: 1543-1548, 2013.
15. Austin PC: An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res 46: 399-424, 2011.
16. Dutch Cancer Registry managed by the Comprehensive Cancer Centre the Netherlands (http://www.iknl.nl)
17. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A and American Joint Committee on Cancer (AJCC): Lung, AJCC Cancer Staging Manual, Seventh Edition. New York, Springer-Verlag, p. 253, 2010.
18. Patel VK, Naik SK, Naidich DP, Travis WD, Weingarten JA, Lazzaro R, Gutterman DD, Wentowski C, Grosu HB and Raoof S: A practical algorithmic approach to the diagnosis and management of solitary pulmonary nodules: part 1: radiologic characteristics and imaging modalities. Chest 143: 825-839, 2013.
19. Macintyre N, Crapo RO, Viegi G, Johnson DC, van der Grinten CP, Brusasco V, Burgos F, Casaburi R, Coates A, Enright P, Gustafsson P, Hankinson J, Jensen R, McKay R, Miller MR, Navajas D, Pedersen OF, Pellegrino R and Wanger J: Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 26: 720-735, 2005.
20. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J and ATS/ERS Task Force: Standardisation of spirometry. Eur Respir J 26: 319-338, 2005.
21. De Leyn P, Lardinois D, Van Schil PE, Rami-Porta R, Passlick B, Zielinski M, Waller DA, Lerut T and Weder W: ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer. Eur J Cardiothorac Surg 32: 1-8, 2007.
22. Yilmaz A, Van Putte BP and Van Boven WJ: Closed chest lobectomy with subxyphoid retraction. Interact Cardiovasc Thorac Surg 13: 549-551, 2011.
23. Donders AR, van der Heijden GJ, Stijnen T and Moons KG: Review: a gentle introduction to imputation of missing values. J Clin Epidemiol 59: 1087-1091, 2006.
24. Allibhai Z, Cho BC, Taremi M, Atallah S, Hope A, Hwang D, Keshavjee S, Tsao M, Yasufuku K, Kim SW and Bezjak A: Surgical salvage following stereotactic body radiotherapy for early-stage NSCLC. Eur Respir J 39: 1039-1042, 2012.
25. Palma DA, Senan S: Improving outcomes for high-risk patients with early-stage non-small cell lung cancer: insights from population-based data and the role of stereotactic ablative radiotherapy. Clin Lung Cancer 14: 1-5, 2013.
26. Veronesi G, Maisonneuve P, Pelosi G, Casiraghi M, Agoglia BG, Borri A, Travaini LL, Bellomi M, Rampinelli C, Brambilla D, Bertolotti R and Spaggiari L: Screening-detected lung cancers: Is systematic nodal dissection always essential? J Thorac Oncol 6: 525-530, 2011.
27. Parashar B, Singh P, Christos P, Arora S, Desai P, Wernicke AG, Delamerced M, Boothe D, Nori D and Chao K: Stereotactic body radiation therapy (SBRT) for early stage lung cancer delivers clinically significant radiation to the draining lymph nodes. J Radiosurg SBRT 2: 339-340, 2013.
28. Reese AS, Feigenberg SJ, Husain A, Webb TJ, Hausner PF, Edelman MJ, Feliciano J, Tkaczuk KH and Sharma NK: Stereotactic ablative radiotherapy (SABR): Impact on the immune system and potential for future therapeutic modulation. Mol Cell Pharmacol 5: 19-25, 2013.
29. Miller GC, Pritchard DJ, Ritts, ivins JC and Pierre RV: Effect of surgery on the quantity of lymphocyte subpopulations. J Surg Res 21: 155-158, 1976.
30. Jones RO, Anderson NH, Murchison JT, Brittan M, Simon EJ, Casali G, Simpson AJ and Walker WS: Innate immune responses after resection for lung cancer via video-assisted thoracoscopic surgery and thoracotomy. Innovations 9: 93-103; discussion 103, 2014.
31. Higuchi M, Yaginuma H, Yonechi A, Kanno R, Ohishi A, Suzuki H and Gotoh M: Long-term outcomes after video-assisted thoracic surgery (VATS) lobectomy versus lobectomy via open thoracotomy for clinical stage IA non-small cell lung cancer. J Cardiothorac Surg 9: 88-8090-9-88, 2014.
32. Lee PC, Nasar A, Port JL, Paul S, Stiles B, Chiu YL, Andrews WG and Altorki NK: Long-term survival after lobectomy for non-small cell lung cancer by video-assisted thoracic surgery versus thoracotomy. Ann Thorac Surg 96: 951-60; discussion 960-961, 2013.
33. Louie AV, Senan S, Patel P, Ferket BS, Lagerwaard FJ, Rodrigues GB, Salama JK, Kelsey C, Palma DA and Hunink MG: When is a biopsy-proven diagnosis necessary before stereotactic ablative radiotherapy for lung cancer?: A decision analysis. Chest 146: 1021-1028, 2014.
34. Belgers EH, Siebenga J, Bosch AM, van Haren EH and Bollen EC: Complete video-assisted thoracoscopic surgery lobectomy and its learning curve. A single-center study introducing the technique in the Netherlands. Interact Cardiovasc Thorac Surg 10: 176-180, 2010.
35. Mokhles S, Nuyttens JJ, Maat AP, Birim O, Aerts JG, Bogers AJ and Takkenberg JJ: Survival and treatment of non-small cell lung cancer stage I-II treated surgically or with stereotactic body radiotherapy: patient and tumor-specific factors affect the prognosis. Ann Surg Oncol 22: 316-323, 2015.